文献速递乳房整形与再造显微修复重建

深度 inferior epigastric perforator 皮瓣乳房重建术后第1天出院的安全性与可行性

How low can we go: Achieving postoperative day 1 discharge after deep inferior epigastric perforator, a safe and feasible goal.
PubMed 文献 · J Plast Reconstr Aesthet Surg · 2025-01-29

该回顾性研究纳入2021年11月至2024年5月由单一术者完成的164个DIEP皮瓣乳房重建(119例患者),平均住院1.5天(SD 0.7天),67例(56.3%)于术后第1天出院,52例(43.7%)于术后第1天之后出院。术后第1天出院者与之后出院者在重建侧别、手术时间和术后第1天阿片类药物摄入量上存在统计学显著差异。作者结论认为,手术、麻醉和专门护理团队的协作使23小时观察或门诊DIEP乳房重建安全可行。

要点

  • 119例患者共行164个DIEP皮瓣乳房重建,平均住院1.5天(SD 0.7天)。
  • 67例(56.3%)于术后第1天出院,其中13例(19.4%)在24小时内回家。
  • 术后第1天出院者与之后出院者在侧别、手术时间和阿片摄入上差异显著。

核心结论

  • 手术、麻醉和专门护理团队的协作使23小时观察或门诊DIEP乳房重建安全可行。
  • 通过达到与假体植入重建的等效性,可将皮瓣重建的可及性扩展至更多患者。

研究设计与样本

  • 回顾性综述,纳入2021年11月至2024年5月由单一术者完成的游离皮瓣乳房重建患者。
  • 共119例患者、164个DIEP皮瓣;回顾人口学、手术细节、阿片类药物摄入、住院时间和术后并发症以评估24小时内出院的安全性。

主要发现

  • 平均住院时间为1.5天(SD 0.7天),67例(56.3%)于术后第1天出院,52例(43.7%)于术后第1天之后出院。
  • 术后第1天出院者中13例(19.4%)在24小时内回家。
  • 术后第1天出院者与之后出院者比较:单侧重建76.1% vs 44.2%(p<0.001),手术时间341.0 vs 439.1分钟(p<0.001),术后第1天阿片摄入4.2 vs 11.3静脉吗啡毫克当量(MME)(p<0.001)。
  • 常见并发症包括腹部伤口裂开(10.1%)、腹部血清肿(5.0%)、乳房伤口裂开(4.9%)和乳房切除皮瓣坏死(3.0%);76例(63.9%)患者无并发症。
  • 皮瓣重建总成功率为100%。

临床怎么用

  • 作者结论认为,手术、麻醉和专门护理团队的协作使23小时观察或门诊DIEP乳房重建安全可行。
  • 作者认为,通过达到与假体植入重建的等效性,可将皮瓣重建的可及性扩展至更多患者。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Although rare reports describe discharge to be possible within 48 hours for patients undergoing autologous breast reconstruction, average length of stay remains around 3 days. This study aimed to demonstrate that patients can be safely discharged within 1 day after deep inferior epigastric perforator (DIEP) flap breast reconstruction. METHODS: A retrospective review was performed of patients who underwent free flap breast reconstruction by a single surgeon from November 2021 to May 2024. Demographics, operative details, opioid ingestion, length of stay, and postoperative complications were reviewed to assess safety of discharge in 24 hours. RESULTS: One hundred sixty-four DIEP flaps were performed on 119 patients. Average length of stay was 1.5 days (SD 0.7 days), with 67 (56.3%) patients discharged on postoperative day 1 (POD1) and 52 (43.7%) discharged after POD1. Of those discharged on POD1, 13 (19.4%) went home in <24 hours. Comparing patients discharged on POD1 to those discharged after POD1, there were statistically significant differences in reconstruction laterality (76.1% vs 44.2% unilateral, p<0.001), operative time (341.0 vs 439.1 minutes, p<0.001), and opioid ingestion on POD1 (4.2 IV morphine milligram equivalents [MME] vs 11.3 MME, p<0.001). Common complications included abdominal wound dehiscence (10.1%), abdominal seroma (5.0%), breast wound dehiscence (4.9%), and breast mastectomy flap necrosis (3.0%). Seventy-six (63.9%) patients had no complications. Overall success rate of flap reconstruction was 100%. CONCLUSION: Collaboration among surgery, anesthesia, and dedicated nursing teams allow 23-hour observation or outpatient DIEP reconstruction to be safe and feasible. By attaining equivalency with implant-based reconstruction, access to flap reconstruction can be extended to more patients.

来源:J Plast Reconstr Aesthet Surg,查看原文。版权归原作者所有。

引用

  1. Nguyen AT, Hu VJ, Clark RC, et al. How low can we go: Achieving postoperative day 1 discharge after deep inferior epigastric perforator, a safe and feasible goal. J Plast Reconstr Aesthet Surg. 2025. PMID: 39923286. doi:10.1016/j.bjps.2025.01.059

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。